MGE ENERGY INC (MGEE) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001161728 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | May 5, 2026 | — | $48.5M | $1.32 | Filing |
| Dec 31, 2025 | Feb 24, 2026 | — | $23.3M | $0.64 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | — | $44.5M | $1.22 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | — | $26.5M | $0.72 | Filing |
| Mar 31, 2025 | May 7, 2025 | — | $41.6M | $1.14 | Filing |
| Dec 31, 2024 | Feb 25, 2025 | — | $22.0M | $0.61 | Filing |
| Sep 30, 2024 | Nov 6, 2024 | — | $40.9M | $1.13 | Filing |
| Jun 30, 2024 | Aug 7, 2024 | — | $23.8M | $0.66 | Filing |
What would MGE ENERGY INC have to report for its valuation to change?
At $72.27, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 9.6% a year, to $6.18. On that path the next quarter needs diluted EPS near $0.79, against $0.72 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 9.6% | 9.6% |
| EPS needed in final year | $6.18 | $6.18 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. MGEE goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.